Description

Sulesomab CAS NO 167747-19-5 is a monoclonal antibody fragment used as a diagnostic imaging agent. This compound is critical for the specific detection and localization of infection sites within the body. It is primarily utilized by pharmaceutical manufacturers, clinical research organizations, and diagnostic imaging centers for the development and application of targeted diagnostic tools.

Application

• Primary component in the formulation of diagnostic radiopharmaceuticals for infection imaging.
• Used in clinical research for the development of novel antibody-based diagnostic agents.
• Key reagent in the production of kits for the scintigraphic detection of osteomyelitis and other soft-tissue infections.
• Essential material for quality control and analytical method development in pharmaceutical manufacturing.
• Used in preclinical studies to evaluate the biodistribution and targeting efficacy of antibody fragments.

Basic Information

Product Name	Sulesomab
CAS No.	167747-19-5
Molecular Formula	C648H1006N174O198S10
Molecular Weight	Approx. 50 kDa (Fab' fragment)
Synonyms	Anti-granulocyte monoclonal antibody Fab' fragment; Sulesomab; LeuTech; 99mTc-Fanolesomab; Technetium (99mTc) fanolesomab; Immunoglobulin G1, anti-(human granulocyte cell surface antigen CD15) (human-mouse monoclonal 1A3 γ1-chain), disulfide with human-mouse monoclonal 1A3 κ-chain, dimer
EINECS	Contact for details

Quality Control

Our Sulesomab is manufactured under strict quality systems. Each batch undergoes comprehensive analytical testing including HPLC for purity, SDS-PAGE for identity and integrity, and endotoxin testing to ensure it meets the stringent requirements for diagnostic and research use. Certificates of Analysis (COA) detailing all specifications are provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. For long-term stability, store lyophilized material at -20°C or below. Reconstituted solutions should be used immediately. This product is hygroscopic (moisture-sensitive) and light-sensitive; appropriate handling procedures are required to maintain stability and potency.

Specification

Item	Specification
Appearance	White to off-white lyophilized powder
Identification (SDS-PAGE)	Complies
Purity (SEC-HPLC)	≥ 95.0% (Monomeric Fab' fragment)
Protein Content (UV)	As per COA
Immunoreactivity	≥ 70%
Endotoxin	< 10 EU/mg
Sterility (where applicable)	Sterile

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.